CHWY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chewy Inc (CHWY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial performance, positive analyst sentiment, and strategic growth initiatives. Despite some hedge fund selling, the stock's fundamentals and growth outlook make it a solid investment opportunity at current levels.
The MACD histogram is positive and expanding, indicating bullish momentum. RSI is neutral at 63.213, showing no overbought or oversold conditions. The stock is trading near its resistance level (R1: 27.367), with converging moving averages suggesting potential consolidation or a breakout. Overall, the technical indicators lean slightly bullish.
Analysts are largely positive, with multiple firms maintaining Outperform or Buy ratings and price targets ranging from $32 to $
Chewy's acquisition of Modern Animal is expected to enhance its Vet business and drive topline and margin growth.
Strong Q4 financial performance, including a 71.99% YoY increase in net income and 80% YoY EPS growth, along with improved gross margins.
The company is leveraging AI and strategic initiatives to drive long-term growth in the digitized pet market.
Hedge funds have significantly increased selling activity, which could indicate short-term bearish sentiment.
Some analysts have lowered price targets, citing cautious outlooks despite strong financials.
The stock's immediate price trend suggests limited short-term upside, with a 50% chance of a slight decline in the next week.
In Q4 2026, Chewy reported revenue of $3.27 billion, up 0.53% YoY. Net income surged 71.99% YoY to $39.2 million, and EPS grew 80% YoY to $0.09. Gross margin improved to 29.4%, up 3.09% YoY. These results highlight strong profitability and operational efficiency.
Analysts are generally bullish on Chewy. Wolfe Research, RBC Capital, and Goldman Sachs have Outperform or Buy ratings with price targets between $39 and $49, citing strong financials, market share gains, and strategic initiatives. While some firms like UBS and Wedbush have lowered price targets, they maintain neutral to positive ratings, reflecting confidence in Chewy's long-term growth prospects.
